US Map / Washington D.C.
State DC

Clinical Trials in Washington D.C.

Recruiting clinical trials with at least one study location in Washington D.C.. Data updated daily from ClinicalTrials.gov.

Total Trials
145
Recruiting Now
145
← Back to US Map
Top Conditions in Washington D.C.
Breast Cancer (6)Head and Neck Squamous Cell Carcinoma (3)Esophageal Cancer (3)Prostate Cancer (3)Prostate Adenocarcinoma (3)Chronic Inflammatory Demyelinating Polyneuropathy (2)Bladder Cancer (2)Multiple Sclerosis (2)Stage IV Lung Cancer AJCC v8 (2)High Grade Glioma (2)Diffuse Intrinsic Pontine Glioma (2)Asthma (2)

Frequently Asked Questions — Clinical Trials in Washington D.C.

How many clinical trials are currently recruiting in Washington D.C.?
ClinicalMetric currently tracks 145 actively recruiting clinical trials with at least one location in Washington D.C.. The total number of registered studies—including active but not currently enrolling trials—is 145. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Washington D.C.?
Washington D.C. hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Head and Neck Squamous Cell Carcinoma, Esophageal Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Washington D.C. serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Washington D.C.?
To join a clinical trial in Washington D.C., browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Washington D.C. maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Washington D.C.

NCT06701682 Phase 2
Recruiting
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilob...
Condition
Acute Respiratory Distress Syndrome (ARDS)
Enrollment
200 pts
Location
United States
Sponsor
PPD Development, LP
View Trial →
NCT04079179 Phase 2
Recruiting
Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histioc...
Condition
Langerhan's Cell Histiocytosis
Enrollment
90 pts
Location
United States
Sponsor
Carl Allen
View Trial →
NCT04647227 Phase 4
Recruiting
SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors
Condition
Hemophilia A With Inhibitor
Enrollment
55 pts
Location
United States
Sponsor
American Thrombosis and Hemost
View Trial →
NCT05096481 Phase 2
Recruiting
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and...
Condition
High Grade Glioma
Enrollment
120 pts
Location
United States
Sponsor
Nationwide Children's Hospital
View Trial →
NCT04376229 N/A
Recruiting
Proton Radiation Therapy Registry
Condition
Cancer, Therapy-Related
Enrollment
5,000 pts
Location
United States
Sponsor
Sidney Kimmel Comprehensive Ca
View Trial →
NCT05907629 N/A
Recruiting
Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vasc...
Condition
Stroke
Enrollment
300 pts
Location
United States
Sponsor
Yale University
View Trial →
NCT07011173 EARLY_Phase 1
Recruiting
Assistance Delivery and Muscle Coordination
Condition
Stroke
Enrollment
30 pts
Location
United States
Sponsor
The Catholic University of Ame
View Trial →
NCT05964439 N/A
Recruiting
Augmented Reality Ultrasound Guidance
Condition
Paracentesis
Enrollment
44 pts
Location
United States
Sponsor
Children's National Research I
View Trial →
NCT06931340 Phase 3
Recruiting
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormona...
Condition
Castration-Sensitive Prostate Carcinoma
Enrollment
1,260 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
View Trial →
NCT04901702 Phase 1, Phase 2
Recruiting
Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Sol...
Condition
Recurrent Solid Tumor
Enrollment
90 pts
Location
United States, Canada
Sponsor
St. Jude Children's Research H
View Trial →
NCT04269902 Phase 3
Recruiting
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia...
Condition
Chronic Lymphocytic Leukemia
Enrollment
247 pts
Location
United States, Canada
Sponsor
National Cancer Institute (NCI
View Trial →
NCT07166094 Phase 3
Recruiting
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Inves...
Condition
Endometrial Cancer
Enrollment
660 pts
Location
United States, Australia, Belgium
Sponsor
Genmab
View Trial →
NCT05256745 Phase 1, Phase 2
Recruiting
RAGE Inhibition to Decrease Cardiotoxicity in Women With Early Breast Cancer
Condition
Cancer Related Cognitive Decline
Enrollment
48 pts
Location
United States
Sponsor
Georgetown University
View Trial →
NCT06624839 Phase 2
Recruiting
Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People ...
Condition
Human Papilloma Virus
Enrollment
120 pts
Location
United States
Sponsor
University of Maryland, Baltim
View Trial →
NCT06927219 N/A
Recruiting
Research Accelerated by You Lupus Registry
Condition
Systemic Lupus Erythematosus (SLE)
Enrollment
10,000 pts
Location
United States
Sponsor
Lupus Foundation of America
View Trial →
NCT06658730 N/A
Recruiting
Long-term Characterization of GORE® TAG® Conformable Thoracic Stent Graft With A...
Condition
Vascular Disease
Enrollment
1,500 pts
Location
United States, Denmark, France
Sponsor
W.L.Gore & Associates
View Trial →
NCT06052267 Phase 3
Recruiting
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol ...
Condition
Asthma
Enrollment
2,700 pts
Location
United States, Argentina, Australia
Sponsor
Teva Branded Pharmaceutical Pr
View Trial →
NCT01193075 N/A
Recruiting
Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT...
Condition
Charcot Marie Tooth Disease
Enrollment
5,000 pts
Location
United States, Australia, Canada
Sponsor
Michael Shy
View Trial →
NCT06526195 N/A
Recruiting
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in ...
Condition
Heart Failure
Enrollment
850 pts
Location
United States, Austria, Czechia
Sponsor
Abbott Medical Devices
View Trial →
NCT04775485 Phase 2
Recruiting
A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With R...
Condition
Low-grade Glioma
Enrollment
141 pts
Location
United States, Australia, Canada
Sponsor
Day One Biopharmaceuticals, In
View Trial →
NCT06544499 Phase 3
Recruiting
A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participan...
Condition
Primary Immune Thrombocytopenia (ITP)
Enrollment
69 pts
Location
United States, Austria, Bulgaria
Sponsor
argenx
View Trial →
NCT06026969 N/A
Recruiting
Pregnancy and Early Neurodevelopmental Outcomes Following In Utero Lyme Disease ...
Condition
Lyme Disease
Enrollment
40 pts
Location
United States
Sponsor
Children's National Research I
View Trial →
NCT03556228 Phase 1, Phase 2
Recruiting
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpr...
Condition
Head and Neck Carcinoma
Enrollment
242 pts
Location
United States, Puerto Rico
Sponsor
VM Oncology, LLC
View Trial →
NCT04914507 N/A
Recruiting
A Prospective Analysis of Long-Term Clinical Outcomes and 3D Spine Growth in Ant...
Condition
Scoliosis Idiopathic
Enrollment
106 pts
Location
United States, Canada
Sponsor
Pediatric Spine Foundation
View Trial →
NCT05346354 Phase 2, Phase 3
Recruiting
Efficacy and Safety Study of Ravulizumab IV in Pediatric Participants With NMOSD
Condition
Neuromyelitis Optica Spectrum Disorder
Enrollment
12 pts
Location
United States, Canada, France
Sponsor
Alexion Pharmaceuticals, Inc.
View Trial →
Page 2 of 6 — 145 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology